This inventor holds 5 USPTO granted patents. Top assignees: Bayer Aktiengesellschaft, Bayer Corporation. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Thomas M Aune: Innovator in Medical Treatments
Introduction
Thomas M Aune is a notable inventor based in Hamden, CT (US), recognized for his contributions to medical treatments. He holds a total of 5 patents, showcasing his innovative approach to addressing health issues.
Latest Patents
Among his latest patents is a method for the inhibition of arthritis using L-type calcium channel antagonists. This invention presents new methods for treating rheumatoid arthritis, demonstrating the effectiveness of compounds such as nimodipine, nisoldipine, and nifedipine in managing this condition. Another significant patent involves anthracene-spiro-pyrrolidines, which are synthesized through reactions with anthracene derivatives and substituted amines. These substances are intended for use as active agents in immunomodulating medicaments.
Career Highlights
Throughout his career, Thomas M Aune has worked with prominent companies, including Bayer Aktiengesellschaft and Bayer Corporation. His work in these organizations has contributed to advancements in pharmaceutical innovations.
Collaborations
He has collaborated with notable individuals in the field, including Eckhard Schwenner and Gaetan Ladouceur, enhancing the impact of his inventions through teamwork and shared expertise.
Conclusion
Thomas M Aune's innovative work in medical treatments, particularly in arthritis and immunomodulation, highlights his significant contributions to the field. His patents reflect a commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile